Treatment of autoimmune arthritis by oral administration of coll

Details Treatment of autoimmune arthritis by oral administration of coll Treatment of autoimmune arthritis by oral administration of coll

1995-06-05

2000-02-01

Achutamurthy, Ponnathapura

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

4241851, 424408, 424409, 424464, 514 2, 514 8, 514 21, 514825, A61K 3900, A61K 3702, A61K 3712

Patent

active

060199717

ABSTRACT:
The invention is directed to a method of treating a T cell-mediated autoimmune disease in animals, including humans, by the oral administration of autoantigens, fragments of autoantigens, or analogs structurally related to those autoantigens, which are specific for the particular autoimmune disease. The method of the invention includes both prophylactic and therapeutic measures.

REFERENCES:
patent: 4804745 (1989-02-01), Koepff et al.
patent: 5075112 (1991-12-01), Lane
patent: 5399347 (1995-03-01), Trentham et al.
patent: 5720955 (1998-02-01), Weiner et al.
patent: 5733547 (1998-03-01), Weiner et al.
patent: 5783188 (1998-07-01), Weiner et al.
Wells, H., J. Infect. Dis. 9:147 (1911).
Ngan, J. et al., J. Immunol. 120:861 (1978).
Gautam, S. et al., J. Immunol. 135:2975 (1985).
Titus, R.G. et al., Int. Arch. Allergy Appl. Immunol. 65:323 (1981).
Nagler-Anderson, C. et al., Proc. Natl. Acad. Sci. USA 83:7443 (1986).
Swierkosz, J.E. et al., J. Immunol. 119:1501 (1977).
Lando, Z. et al., Nature 287:551 (1980).
Lando, Z. et al., J. Immunol. 126:1526 (1981).
Sriram, S. et al., Cell. Immunol. 75:378 (1983).
Alvord, E.C. et al., Annals of Neurol. 6:461 (1979).
Alvord, E.C. et al., Annals of Neurol. 6:469 (1979).
Alvord, E.C. et al., Annals of Neurol. 6:474 (1979).
Traugott, U. et al., J. Neurol. Sci. 56:65 (1982).
Raine, C.S. et al., Lab. Invest. 48:275 (1983).
McKenna, R.M. et al., Cell. Immun. 81:391 (1983).
Strejan, G.H. et al., Cell. Immun. 84:171 (1984).
McKenna, R.M. et al., Cell. Immun. 88:251 (1984).
Burns, J. et al., Neurology 36:92 (1986).
Belik, Y. et al., Vopr. Med. Khim. 24:372 (1978).
Braley-Mullen, H. et al., Cell. Immun. 39:289 (1978).
Kardys, E. et al., J. Immunol. 127:862 (1981).
Holoshitz, J. et al., J. Immunol. 131:2810 (1983).
Mokhtarian, F. et al., Nature 309:356 (1984).
McDermott, J.R. et al., J. Neuro. Sci. 46:137 (1980).
Raziuddin, S. et al., J. Immunol. 128:2073 (1982).
Alvord, E.C. et al., Annals NY Acad. Sci. 122:333 (1965).
Eylar, E.H. et al., Nature 236:74 (1972).
Schoen, R.T. et al., J. Immunol. 128:717 (1982).
Eylar, E.H., Adv. Exp. Med. Biol. 98:259 (1978).
Bitar, D.M., Cell. Immunol. 112:364 (1988).
Whitacre, C.C. et al., Abs. 6th Int'l. Cong. Immunol., Toronto (Jul. 1986) (Dist. to Reg. Attendees Upon Request, May 1986).
Higgins, P.J. et al., Annals Neurol. 20:161 Abstract No. P154 (1986).
Whitacre, C.C. et al., Titles of Workshop Presentations, No. 615-09 5th Int'l. Congr. of Immunol., Kyoto, Japan (1983).
Higgins, P.J. et al., J. Neurolimmunol. 16:77 (1987).
Gonsette, R.E. et al., J. Neurol. 216:27 (1977).
Myers, L.K. et al., J. Immunol. 143:3976 (1989).
Myers, L.K. et al., J. Exp. Med. 170:1999 (1989).
Lider, O. et al., J. Immunol. 142:748 (1989).
Higgins, P.J. et al., J. Immunol. 140:440 (1988).
Campbell, B. et al., Arch. Neurol. 29:10 (1973).
Trentham, D.E. et al., J. Clin. Invest. 66:1109 (1980).
Thompson, H.S.G. et al., Clin. Exp. Immunol. 64:581 (1985).
Mowat, A.M., Immunol. Today 8:93 (1987).
AutoImmune Press Release of May 12, 1997.
Allegreta, M., et al., Science 247:718, 1990.
Cremer, et al., J. Immunol. 87:2995, 1983.
Englert, et al., Cell. Immunol. 87:357, 1984.
Janeway, Nature 341:482-83, 1989.
Lane, I. William et al., Sharks Don't Get Cancer, Avery Publishing Group Inc., updated edition 1993.
Miller, A., et al., J. Exp. Med. 174:791, 1991.
Miller, A., et al., Proc. Natl. Acad. Sci. USA 89:421, 1992.
Pinals, R. S., et al., Arthritis Rheum. 24:1308, 1981.
Rama, et al., Connective Tissue Research 12:111, 1984.
Santos, L. M. B., et al., J. Immunol. 150:115A, 1993.
Sewel, K.L. and Trentham, D.E., The Lancet 341:283, 1993.
Steinbrocker, O., et al., JAMA 140:659, 1949.
Trentham, D. E., et al., Science 261:1727, 1993.
Weinblatt, M.E., et al., N. Eng. J. Med. 312:818, 1985.
Weiner, H. L., et al., Science 259:1321, 1993.
Whitacre, C. C., et al., J. Immunol. 147:2155, 1991.
Williams, H. J. et al., Arthritis Rheum. 31:702, 1988.
Zhang, Z. J., et al., J. Immunol. 145:2489, 1990.
Higgins et al., J. Immunology, 140:440-445, 1988.
Eylar, Adv. Exp. Med. Bio., 98:259-281, 1978.
Sriram et al., Cell. Immunol., 75:378-382, 1983.
Nagler-Anderson et al., PNAS, 83:7443-7446, 1986.
Schoen, J. Immunol., 128:717-719, 1982.
Higgins et al., Annals Neurology, abstract No. P154, 1986.
Whitacre et al., 6th Int'l. Cong. Immunol., abstract No. 3.62.21, 1986.
Zamvil et al., Nature, 324:258-260, 1986.
Fritz et al., J. Immunol., 134:2328-2332, 1985.
Fritz et al., J. Immunol., 130:191-194, 1983.
Pettinelli et al., J. Immunol., 129:1209-1211, 1982.
Whitaker et al., J. Bio. Chem, 250:9106-9111, 1975.
Thompson et al., Clin. Exp. Immunol., 64:581-586, 1985.
Lider et al., J. Immunol., 142:748-752, 1989.
Friedman et al., PNAS, 91:6688-6692, 1994.
Bitar, dissertation entitled, The Suppressive Effects of Oral Myelin Basic Protein . . . , 1986.
Nagler-Anderson, dissertation entitled, Immunoregulation of an Exp. Model of Autoimmunity, 1986.
Rothbart, 1st Forum in Virology, pp. 518-520, 1986.
Bitar et al., Cell. Immunol., 112:364-370, 1988.
Eylar et al., Neurochem. Research, 4:249-258, 1979.
Kagnoff, Oral Tolerance, pp. 248-269, 1982.
Mowat, Immunol. Today, 8:93-98, 1987.
Weiner et al., Science, 259:1321-1324, 1993.
Campbell et al., Arch. Neurol., 29:10-15, 1973.
Carnegie et al.,Immunol. 19:55-63, 1970.
Fritz et al., J. Immunol., 130:1024-1026, 1983.
Hashim et al., Arch. Biochem. and Biophy., 156:287-297, 1973.

Affiliated with

Also associated with

Rating

Treatment of autoimmune arthritis by oral administration of coll does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of autoimmune arthritis by oral administration of coll, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of autoimmune arthritis by oral administration of coll will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-935165